Top 10

Top 10 Pharmaceutical companies in Pakistan 2020

We categorize the Top Ten Highest profit-making Pharmaceuticals in Pakistan according to their growth in the Pharma sector. This data can be a measuring tool and save readers time instead of navigating on the internet for the Top performers of the Industry.

In 1947, there was hardly any Pharma industry in Pakistan. Today there are more than 750 Pharma companies in the country out of which 55% are Nationals and 45% are MNCs fulfill more than 95% of the domestic requirements.

The Drug Regulatory Department of Pakistan works under the NHS&R (Ministry of National Health Service and Regulations) assured to establish a separate desk to address issues related to the Pharma Exporters of Pakistan. In 2018, Federal Minister for Health Services emphasized on the need of harmonization and facilitation of pharmaceutical exports by engaging customs and the Trade and Development Authority of Pakistan (TDAP) for resolution of the grievances of Pharma Exporters. 

The Health Authority has directed its inspectors to check and monitor the stocks of protective equipment against Coronavirus and such equipment must be available for use in the country. 


‘Through improved exports of pharmaceutical and alternative medicine, it is the Sixth largest sector contributing to the overall exports of Pakistan’

Pharma exports of Pakistan crossed US$ 230 million with the potential to expand up to US$ 2 billion.  The Drug Regulatory Authority also forecasted that the market will be valued at PKR 311 billion (equals to $2.9 billion) in 2020.

According to their growth rate, here are the Top ten Pharmaceutical companies in Pakistan:

  • GSK – 32,388 million
  • GETZ Pharma – 28,363 million
  • ABBOTT – 26,688 million
  • SEARLE – 24,561 million
  • SAMI Pharma – 24,055 million
  • MARTIN-DOW – 18,869 million
  • HIGH Q – 15,352 million
  • HILTON Pharma – 13,638 million
  • GSK Consumer – 13,348 million
  • Sanofi-Aventis – 13,094 million

Value Rs million in Pak Rupees

The pharmaceutical business reflected a growth of 1.8% compared to the same period last year, which depicts the impact of the economic slowdown in the country. Our trade business delivered a growth of 8% over this period.

GSK – GlaxoSmithKline website: (ticker symbol GSK at LSE/NYSE) 

Key Person: Ms Erum Shakir Rahim – CEO

GlaxoSmithKline Pakistan is a subsidiary of British GlaxoSmithKline Headquartered in Brentford, UK and an operational HQ in the USA. GSK is one of the world’s largest pharmaceutical companies that discovers, develops, manufactures and markets human health products. 

GSK produces medicines that treat major disease areas such as Asthma, anti-viral, infection, mental health, Diabetes, Cardiovascular and digestive conditions. 

During this period, the Company achieved net sales of Rs. 25.8 billion, which also includes sales of Rs. 3.2 billion to GlaxoSmithKline Consumer Healthcare Pakistan Limited on account of products manufactured by the Company


GSK is a leader in the important area of vaccines and is developing new treatments for cancer.  GSK has two main business divisions, Pharmaceuticals & Consumer-Healthcare. The pharmaceuticals division is the largest part of GSK’s businesses where consumer healthcare businesses consist of over-the-counter medicines, oral care products, such as the toothpaste brands Aquafresh, Macleans and Sensodyne, and nutritional healthcare drinks. In the past few years, the five largest-selling GSK products are Seretide/Advair for asthma & COPD, Paxil/Seroxat and Wellbutrin anti-depression drugs, Avandia/Avandamet for type 2-diabetes and the famous antibiotic Augmentin. 

GSK produces a broad range of products of special importance to developing countries, including Anti-malaria drugs, Zentel (albendazole), lymphatic filariasis, Pentosam, against leishmaniasis, Anti-retroviral (ARVs).

GETZ Pharma – website Key person: Mr Khalid Mehmood -MD & CEO

For the information of our international readers, according to their website, Getz Pharma is the only manufacturing facility – along with its Quality Control Lab – in Pakistan which is approved by the WHO-United Nations. Getz’s manufacturing facility is also certified and approved by the PIC (Pharmaceutical Inspection Co-operation Scheme). 

Getz Pharma is the fastest-growing company with-in most countries where it operates and operates in South-East Asia, Central-Asia and Africa. 

Getz Pharma provides affordable & high-quality solutions in the areas of cardiometabolic, Hepatology, Gastroenterology, COPD, Urology, Gynecology, Orthopedics and Rheumatology and also in infectious Diseases. Getz received FPCC&I export Trophy for six consecutive years in the year 2012 and the second largest contributor to the national Exchequer in terms of taxes & duties. 

According to the CEO Mr Khalid Mehmood, ‘our average annual growth rate has been 35 percent per annum, for the last 20 years’. As it is mentioned on the Getz website, Getz accounts for about 35% of total Pharmaceuticals exports in Pakistan.

ABBOT – Pakistan Key person: Mr Syed Anis Ahmed – CEO

ABBOTT is making a difference in over 150 countries with 99,000 employees working around the world to make a lasting impact on health. Abbott Laboratories (Pakistan) Ltd is a public limited company incorporated in Pakistan on July 02, 1948, and its shares listed on (PSX) Pakistan Stock Exchange.

ABBOTT’s businesses areas including NUTRITION, DIAGNOSTICS, VASCULAR CARE, DIABETES and PHARMACEUTICALS and its a Market leader in Blood screening, Immunoassay diagnostics, Adult & Pediatric Nutrition with trusted Brands like PediaSure, Ensure, BRUFEN, KLACID and Glucerna.

According to ABBOTT’s unaudited-interim report (2019), Sales increased by 3%, nutritional sales increased by 15%, whereas pharmaceutical sales decrease by 1% with a Gross Profit for the period was 28%.

Abbott has been dedicated to helping people in Pakistan live healthier lives through its nutritional products & diabetes devices. ABBOTT Pakistan has more than 1,400 employees in Karachi, Lahore, Peshawar and Rawalpindi with distribution depots in Islamabad, Lahore and Multan. 

SEARLE share price 169.76 as on Mar 19, 2020, 6:08 pm

Key person: Syed Nadeem Ahmed – CEO & MD

The SEARLE Company Ltd (TSCL) is a holding company, incorporated in Pakistan in 1965. It is a subsidiary of G.D. Searle & Co., U.S.A. SEARLE is a pharmaceutical manufacturer and principally engages in the sale of food & consumer products.  SEARLE acquired by IBL Group in 1993 operates through different segments, Pharmaceutical & Consumer. SEARLE is one of the leading pharmaceutical companies in Pakistan having two state-of-the-art manufacturing facilities in Karachi & Lahore.

The Pharmaceuticals sales for 2019 was PKR 14,207 million, where consumer sales are PKR 3,855 million

SEARLE highest selling products include Adronil, Byscard, Canderel, Extor, Ezium, Hydryllin, Levoxin, Lomotil, Nuberol Forte, Rhulef, Peditral, Selanz SR, Vitrum, Xaroban, Xadine, and Zenbar.

On May 2019, SEARLE announced that it is acquiring OBS Pakistan Ltd. OBS is a strategic pharmaceutical organization with its brands already established in Pakistan.

SAMI – website Key person: Mr Shamim Ahmed –Chairman

SAMI Pharma with its Head Office in PECHS, Karachi has a history 40 years of manufacturing excellence and it is Pakistan’s third largest Pharmaceutical with more than eighty distributors across the country. SAMI’s products cover Analgesics, Anti-infectives, Gastrointestinal Drugs & Supplements. 

“SAMI Cares for Humanity”

A few years back, Pharma Industry was dominated by multinational companies (MNCs) in Pakistan but SAMI developed branded generics of the best quality. It embraces the challenge of defeating Pakistan’s burden of communicable & non-communicable diseases by selling products at prices that respect national resource constraints.

MARTIN-DOW – website Key person: Mr Javed Mohammad – MD & CEO

Martin-Dow – ESC economically significant company – was established in 1995 as one of the largest healthcare groups in Pakistan and the top Pharma in the biggest city of Pakistan, Karachi. Martin-Dow has more than 1000 employees in Pakistan. With over 60 brands Martin-Dow’s research-based products and generics are developed at its GMP (Goods Manufacturing Practices) compliant manufacturing factory in Karachi.

Martin Dow has three major business segments, Licensed products from world ROCHE (which was acquired in 2010), Biocodex (France), Japan, Teijin (Switzerland). Martin-Dow developed and commercialized different therapeutic segments, Anti-Infectives, Cardiology, Dermatology, Neuropsychiatry and Pain Management.

HIGH-Q – website: Key person: Mr Atif Iqbal – Executive Director

HIGH Q was founded in 1994 as ‘HIGH-Q International’. In 2007, High-Q launched a state of the art HIGH-Q Pharmaceuticals manufacturing plant. High-Q deals in the products from different health segments namely, Anti-allergy, Cardiology, Diabetes, Gynecology, Hepatology, ENT, Neurology and Surgical prophylaxis.

According to a statement mentioned on their website, HIGH-Q Group is growing at an average of 30% over the past 5 years…

HIGH-Q’s flagship brands ‘FREEHALE, LCYN, ONE-3, POLYMALT, QUFEN and RULING’ emerged in the Top Ten best launch category. 

HILTON – website – Key Person: Mr Muhammad Yasin Malik – Chairman

HILTON Pharma was incepted in 1969 as an Indenting organization. Right after one year, HILTON joined hands with Vitamin manufacturer ‘DSM’. The first amino-acid was launched by HILTON as ‘L-Lysine’ in 1972. 

Finally, HILTON was established as a ‘Pharma manufacturer’ in 1976. Hilton is honoured to manufacture the first Chinese Pharma product ‘Diazine Tablets’ in Pakistan. HILTON Pharma has a unique GMP state-of-the-art facility in Korangi Industrial Area, Karachi. 

HILTON manufactures both Live Stock (Veterinary) and Human range pharmaceuticals.  For Humans, it ranges from Anti-Diabetics, Anti-Fibrinolytic, Anti-Gout, Anti-Asthmatic, Anti-Hypertensive, Anti-Lipids, Central Nervous system, Fertility, GI, Multi-Vitamin and Pain Management.

GSK–Consumer website: 200.30 

GSK Consumer is an associate of GSK, UK. It is one of the world’s largest consumer healthcare companies. GSK-Consumer is dedicated to transforming the lives and futures of millions of people by developing a range of products in the areas of ‘Gastrointestinal, Nutrition, Oral Health, Pain Relief, Respiratory, and Skin Care.

GSK-Consumer manufactures products from Actifed, ENO, Horlicks, Iodex, to Panadol and Panadol-CF & Sensodyne…

GSK-Consumer is a global healthcare company. It researches the market and develops a broad range of innovative products in three primary areas of Pharmaceuticals, Vaccines and Consumer Healthcare.

SANOFI – website: Key person: Mr Dr Asim Jamal – Country Chair & MD 

For more than 52 years, Sanofi has been present in Pakistan. Sanofi was incorporated in Pakistan as ‘Hoechst Pakistan Limited’. In June 1996, Hoechst Pakistan changed its name to Hoechst Marion Roussel Ltd and merged their life-science business into a new company ‘Aventis’. In 1997, Clariant Pakistan ltd bought the company’s chemical business.

Aventis acquired Sanofi and became Sanofi-Aventis in the year 2004.

With over 116 products, Sanofi-Aventis is the 7th largest pharmaceutical company in Pakistan.

While Sanofi was a subsidiary of SECIPE France (who owned 53% of shares), in October 2018, Sanofi announced transfer SECIPE’s shareholdings to Zentiva NV, incorporated in the Netherlands. Sanofi Aventis Pakistan continues to be owned by the same company.

You can also check Top 10 pharma in Pakistan 2019.

Show More

Leave a Reply

Your email address will not be published. Required fields are marked *


Adblock Detected

Please consider supporting us by disabling your ad blocker